<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, the stratified squamous epithelium lining the esophagus is replaced by specialized intestinal-type columnar epithelium </plain></SENT>
<SENT sid="1" pm="."><plain>The prevalence of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> has ranged from 0.9% to 4.5% </plain></SENT>
<SENT sid="2" pm="."><plain>The rate of progression from <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is 0.5% per patient-year </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="49200">Proton-pump inhibitors</z:chebi> are the mainstay of symptom control in Barrett's patients </plain></SENT>
<SENT sid="4" pm="."><plain>Nondysplastic Barrett's and Barrett's with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (LGD) are typically managed by periodic surveillance </plain></SENT>
<SENT sid="5" pm="."><plain>Radiofrequency ablation is being evaluated as a modality for managing nondysplastic Barrett's and Barrett's with LGD </plain></SENT>
<SENT sid="6" pm="."><plain>The options for the management of Barrett's patients with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) include endoscopic therapy, surgery, and intensive surveillance until biopsy reveals <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Endoscopic therapy involves endoscopic mucosal resection (EMR) and ablation </plain></SENT>
<SENT sid="8" pm="."><plain>More aggressive techniques such as endoscopic submucosal dissection and larger segment endoscopic mucosal resection are under study </plain></SENT>
<SENT sid="9" pm="."><plain>In this review, we discuss the diagnosis and management of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The recommendations from the major gastroenterologic societies and the current and investigational endoscopic modalities for the management of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with and without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> are reviewed </plain></SENT>
</text></document>